BSE Live
Feb 11, 16:01Prev. Close
74.80
Open Price
74.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 11, 15:42Prev. Close
74.18
Open Price
74.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Alpa Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -0.66 | -2.45 | -2.08 | 0.25 | 0.43 | |
| Diluted EPS (Rs.) | -0.66 | -2.45 | -2.08 | 0.25 | 0.43 | |
| Cash EPS (Rs.) | 2.22 | 1.86 | 0.17 | 0.73 | 0.96 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 41.14 | 41.97 | 44.42 | 46.50 | 46.24 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 41.14 | 41.97 | 44.42 | 46.50 | 46.24 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 27.28 | 26.95 | 26.67 | 26.20 | 39.38 | |
| PBDIT/Share (Rs.) | 2.95 | 2.96 | 1.64 | 1.48 | 1.18 | |
| PBIT/Share (Rs.) | 0.07 | -1.34 | -0.60 | 1.00 | 0.65 | |
| PBT/Share (Rs.) | -1.29 | -2.35 | -1.53 | 0.40 | 0.51 | |
| Net Profit/Share (Rs.) | -0.66 | -2.45 | -2.08 | 0.25 | 0.43 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 10.81 | 10.98 | 6.16 | 5.64 | 3.00 | |
| PBIT Margin (%) | 0.24 | -4.98 | -2.25 | 3.82 | 1.66 | |
| PBT Margin (%) | -4.72 | -8.73 | -5.72 | 1.51 | 1.30 | |
| Net Profit Margin (%) | -2.43 | -9.09 | -7.78 | 0.95 | 1.09 | |
| Return on Networth / Equity (%) | -1.61 | -5.83 | -4.67 | 0.54 | 0.92 | |
| Return on Capital Employed (%) | -1.60 | -5.45 | -4.28 | 0.52 | 0.92 | |
| Return on Assets (%) | -1.08 | -4.06 | -3.50 | 0.40 | 0.69 | |
| Total Debt/Equity (X) | 0.33 | 0.23 | 0.15 | 0.11 | 0.10 | |
| Asset Turnover Ratio (%) | 44.73 | 44.75 | 45.04 | 42.40 | 63.99 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.73 | 1.63 | 1.94 | 1.95 | 1.82 | |
| Quick Ratio (X) | 2.55 | 1.23 | 1.35 | 1.41 | 1.30 | |
| Inventory Turnover Ratio (X) | 7.63 | 4.36 | 4.22 | 3.55 | 5.09 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 100.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 100.00 | 100.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | -20.33 | 30.43 | 30.44 | 28.67 | 32.14 | |
| EV/Net Operating Revenue (X) | -0.35 | 0.54 | 0.54 | 0.52 | 0.39 | |
| EV/EBITDA (X) | -3.28 | 4.88 | 8.80 | 9.22 | 12.92 | |
| MarketCap/Net Operating Revenue (X) | 0.40 | 0.36 | 0.30 | 0.33 | 0.29 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 100.00 | 100.00 | |
| Price/BV (X) | 0.27 | 0.23 | 0.18 | 0.19 | 0.24 | |
| Price/Net Operating Revenue | 0.40 | 0.36 | 0.30 | 0.33 | 0.29 | |
| Earnings Yield | -0.06 | -0.25 | -0.26 | 0.03 | 0.04 |
04.12.2025
Alpa Labs Consolidated September 2025 Net Sales at Rs 26.26 crore, up 5.29% Y-o-Y
27.11.2025
Alpa Labs Standalone September 2025 Net Sales at Rs 25.63 crore, up 2.78% Y-o-Y
12.06.2025
Alpa Labs Standalone March 2025 Net Sales at Rs 39.11 crore, up 65.68% Y-o-Y
05.06.2025
Alpa Labs Consolidated March 2025 Net Sales at Rs 39.92 crore, up 69.1% Y-o-Y
04.12.2025
Alpa Labs Consolidated September 2025 Net Sales at Rs 26.26 crore, up 5.29% Y-o-Y
27.11.2025
Alpa Labs Standalone September 2025 Net Sales at Rs 25.63 crore, up 2.78% Y-o-Y
12.06.2025
Alpa Labs Standalone March 2025 Net Sales at Rs 39.11 crore, up 65.68% Y-o-Y
05.06.2025
Alpa Labs Consolidated March 2025 Net Sales at Rs 39.92 crore, up 69.1% Y-o-Y